• BioLizard to Develop AI Algorithm for Novigenix Colon Cancer Detection Test

    • September 23, 2019
    • Posted By : admin
    • 0 Comment
    •   95 views

    Novigenix said today that it has tapped Belgium-based startup bioinformatics firm BioLizard to develop an artificial intelligence-based algorithm to support the transition of its Colox immuno-transcriptomic RT-PCR product onto a new platform. The algorithm will also underlie new Novigenix products under development.

    Switzerland-based Novigenix is in the process of migrating Colox, an mRNA-based assay for early detection of colorectal cancer development to the new LITOseek system, which relies on next-generation sequencing rather than RT-PCR. LITOseek previously had been dubbed Colox+. 

    “Partnering with BioLizard helps us to fast-track the development of our LITOseek platform,” Novigenix CEO Jan Groen said in a statement. “Our current Colox customers will strongly benefit from this new development once we launch our new colon cancer test on the LITOseek platform, but it will also fast-track the progress of new products that are currently in the pipeline.”

  95 views

You Might Also Like

No comments found

LEAVE COMMENT

Archive

Offers
error: Content is protected !!